loadpatents
Patent applications and USPTO patent grants for Tadesse; Dawit.The latest application filed is for "6,7-cyclicmorphinan derivatives and use thereof".
Patent | Date |
---|---|
6,7-cyclicmorphinan derivatives and use thereof Grant 10,435,406 - Kassick , et al. O | 2019-10-08 |
Substituted piperidin-4-amino-type compounds and uses thereof Grant 10,118,927 - Brown , et al. November 6, 2 | 2018-11-06 |
6,7-cyclicmorphinan Derivatives And Use Thereof App 20180265510 - Kassick; Andrew ;   et al. | 2018-09-20 |
Triazine carboxamides as sodium channel blockers Grant 10,000,475 - Tadesse , et al. June 19, 2 | 2018-06-19 |
Quinazolin-4(3H)-one-type piperidine compounds and uses thereof Grant 9,951,038 - Tadesse April 24, 2 | 2018-04-24 |
Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof Grant 9,598,447 - Tadesse , et al. March 21, 2 | 2017-03-21 |
Substituted Piperidin-4-amino-type Compounds And Uses Thereof App 20160272640 - Brown; Kevin ;   et al. | 2016-09-22 |
Quinazolin-4(3h)-one-type Piperidine Compounds And Uses Thereof App 20160002203 - Tadesse; Dawit | 2016-01-07 |
Triazine Carboxamides As Sodium Channel Blockers App 20150353512 - Tadesse; Dawit ;   et al. | 2015-12-10 |
Triazine carboxamides as sodium channel blockers Grant 9,120,786 - Tadesse , et al. September 1, 2 | 2015-09-01 |
Heterocyclic aspartyl protease inhibitors Grant 8,829,036 - Zhu , et al. September 9, 2 | 2014-09-09 |
Triazine Carboxamides As Sodium Channel Blockers App 20140249128 - Tadesse; Dawit ;   et al. | 2014-09-04 |
Heterocyclic aspartyl protease inhibitors Grant 8,778,980 - Zhu , et al. July 15, 2 | 2014-07-15 |
Phosphorus-substituted Quinoxaline-type Piperidine Compounds And Uses Thereof App 20140128346 - Tadesse; Dawit ;   et al. | 2014-05-08 |
Heterocyclic aspartyl protease inhibitors Grant 8,691,831 - Zhu , et al. April 8, 2 | 2014-04-08 |
Heterocyclic aspartyl protease inhibitors Grant 8,691,833 - Zhu , et al. April 8, 2 | 2014-04-08 |
Heterocyclic Aspartyl Protease Inhibitors App 20130018066 - Zhu; Zhaoning ;   et al. | 2013-01-17 |
Heterocyclic Aspartyl Protease Inhibitors App 20120276118 - Zhu; Zhaoning ;   et al. | 2012-11-01 |
Heterocyclic Aspartyl Protease Inhibitors App 20120231017 - ZHU; ZHAONING ;   et al. | 2012-09-13 |
Heterocyclic Aspartyl Protease Inhibitors App 20120231018 - Zhu; Zhaoning ;   et al. | 2012-09-13 |
Heterocyclic aspartyl protease inhibitors Grant 8,242,112 - Zhu , et al. August 14, 2 | 2012-08-14 |
Heterocyclic Aspartyl Protease Inhibitors App 20110218194 - Zhu; Zhaoning ;   et al. | 2011-09-08 |
Heterocyclic aspartyl protease inhibitors Grant 7,973,067 - Zhu , et al. July 5, 2 | 2011-07-05 |
Heterocyclic Aspartyl Protease Inhibitors App 20100292203 - Zhu; Zhaoning ;   et al. | 2010-11-18 |
Heterocyclic aspartyl protease inhibitors Grant 7,763,609 - Zhu , et al. July 27, 2 | 2010-07-27 |
Heterocyclic aspartyl protease inhibitors Grant 7,700,603 - Zhu , et al. April 20, 2 | 2010-04-20 |
Heterocyclic Aspartyl Protease Inhibitors App 20090258868 - Zhu; Zhaoning ;   et al. | 2009-10-15 |
Heterocyclic aspartyl protease inhibitors App 20080200445 - Zhu; Zhaoning ;   et al. | 2008-08-21 |
Heterocyclic aspartyl protease inhibitors App 20060111370 - Zhu; Zhaoning ;   et al. | 2006-05-25 |
Electric arc furnace controller Grant 6,274,851 - Mulcahy , et al. August 14, 2 | 2001-08-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.